At Starpharma, we recognise our important role as a biopharmaceutical company to improve patient outcomes. A key part of this is shaping the future of our industry to ensure it grows sustainably. We are committed to developing innovative products that will positively impact society.
To ensure that we remain forward-thinking, we continually strive to improve our sustainability practices. Our corporate governance principles and Code of Conduct provide a framework for ethical and responsible behaviour at all levels of our organisation, from the Board and management to all other employees.
Starpharma publishes an Environment, Social and Governance (ESG) Report each year alongside its Annual Report 2023. Our ESG Report presents Starpharma's ESG framework and practices, covering four main areas: Environment, Our People, Products and Patient Health, and Governance.
It also details the sustainability-related risks and opportunities that are important to Starpharma and our stakeholders. Our focus is on the evolving, perceived and potential issues arising during pharmaceutical product research and development, registration, supply and commercialisation.